<DOC>
	<DOCNO>NCT00837993</DOCNO>
	<brief_summary>Primary Objective : - To reclassify histologic grade serous ovarian cancer specimens patient enrol Gynecologic Oncology Group ( GOG ) protocol 158 use two-tier system . Secondary Objective : - To determine overall progression-free survival patient serous carcinoma ovary treat GOG protocol 158 reclassify accord tumor grade ( low vs. high ) . Tertiary Objective : - To correlate histologic grade prognostic factor .</brief_summary>
	<brief_title>Ancillary Study GOG 158 : Survival Analysis Based Reclassification Two-Tier Grading System</brief_title>
	<detailed_description>The purpose study describe progression-free overall survival patient treat GOG protocol 158 tumor reclassify two-tier grading system . Although universal grade system exists , Malpica et al . recently publish data clinically meaningful two-tier grading system serous ovarian carcinoma ( Malpica et al. , American Journal Surgical Pathology , 2004 ) . Tumor grade show important prognostic factor woman epithelial ovarian cancer , especially early stage carcinoma . While less consensus regard prognostic significance grade late stage tumor , researcher note patient low-grade advanced disease may longer survival high-grade lesion ( Bodurka-Bevers et al. , Gynecologic Oncology , 2000 ) .</detailed_description>
	<criteria>All patient enrol GOG protocol 158 diagnosis serous carcinoma ovary .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Advanced Stage Serous Carcinoma Ovary</keyword>
	<keyword>serous ovarian carcinoma</keyword>
	<keyword>Ovary</keyword>
	<keyword>GOG Protocol 158</keyword>
	<keyword>Survival Analysis</keyword>
	<keyword>Pathology Slides</keyword>
	<keyword>Two-tier Grading System</keyword>
	<keyword>Ancillary Study</keyword>
</DOC>